Publications by authors named "Takeuchi Junko"

Claim this Profile
L
Low Levels of Postvaccination Hemagglutination Inhibition Antibodies and Their Correlation With Influenza Protection Among Healthcare Workers During the 2024-2025 A/H1N1 Outbreak in Japan.
Shohei Yamamoto, Tetsuya Mizoue, Mugen Ujiie, Kumi Horii, Junko S Takeuchi

J Infect Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide association study of common side effects following COVID-19 booster vaccination in a cohort of corporate employees in Japan.
Yosuke Omae, Seik-Soon Khor, Mihoko Shimada, Yosuke Kawai, Taihei Yamaguchi, Junko S Takeuchi

Sci Rep· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large-scale screening of SARS-CoV-2 variants in Tokyo, Japan: A 3-year and 9-month longitudinal survey.
Junko S Takeuchi, Kei Yamamoto, Masami Kurokawa, Kento Fukano, Azusa Kamikawa

Glob Health Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SGV-caller: SARS-CoV-2 genome variation caller.
Jiaqi Wu, Kirill Kryukov, Junko S Takeuchi, So Nakagawa

Heliyon· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural basis for hepatitis B virus restriction by a viral receptor homologue.
Kaho Shionoya, Jae-Hyun Park, Toru Ekimoto, Junko S Takeuchi, Junki Mifune

Nat Commun· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular epidemiology of SARS-CoV-2 genome sentinel surveillance in commercial COVID-19 testing sites targeting asymptomatic individuals during Japan's seventh epidemic wave.
Teiichiro Shiino, Junko S Takeuchi, Hajime Ohyanagi, Moto Kimura, Yukumasa Kazuyama

Sci Rep· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the SARS-CoV-2 RNA detection reagent LAMPdirect Genelyzer KIT using nasopharyngeal swab and saliva samples.
Junko S Takeuchi, Kento Fukano, Yumiko Kito, Kei Yamamoto, Moto Kimura

Diagn Microbiol Infect Dis· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relapse of COVID-19 and Viral Evolution in a Patient With Good Syndrome: A Case Report.
Mika Iwasaki, Masao Hashimoto, Junko S Takeuchi, Yusaku Kusaba, Moto Kimura, Junko Terada-Hirashima

Cureus· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of single booster dose of KD-414 inactivated COVID-19 vaccine in adults: An open-label, single-center, non-randomized, controlled study in Japan.
Junko Terada-Hirashima, Yuki Takamatsu, Yosuke Shimizu, Yukari Uemura, Junko S Takeuchi

Hum Vaccin Immunother· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preinfection Neutralizing Antibodies, Omicron BA.5 Breakthrough Infection, and Long COVID: A Propensity Score-Matched Analysis.
Shohei Yamamoto, Kouki Matsuda, Kenji Maeda, Kumi Horii, Kaori Okudera, Junko S Takeuchi

J Infect Dis· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 HaploGraph: visualization of SARS-CoV-2 haplotype spread in Japan.
So Nakagawa, Toshiaki Katayama, Lihua Jin, Jiaqi Wu, Kirill Kryukov, Junko S Takeuchi

Genes Genet Syst· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2.
Shohei Yamamoto, Kouki Matsuda, Kenji Maeda, Yusuke Oshiro, Natsumi Inamura, Junko S Takeuchi

BMC Infect Dis· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the severe COVID-19 prognostic value of serum IL-6, IFN-λ3, CCL17, and calprotectin considering the timing of clinical need for prediction.
Kei Yamamoto, Yusuke Ohsiro, Tetsuya Suzuki, Michiyo Suzuki, Sayaka Miura, Junko S Takeuchi

PLoS One· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralizing antibodies after three doses of the BNT162b2 vaccine, breakthrough infection, and symptoms during the Omicron-predominant wave.
Shohei Yamamoto, Kouki Matsuda, Kenji Maeda, Kumi Horii, Kaori Okudera, Junko S Takeuchi

Int J Infect Dis· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of the Japanese version of EPDS-P for indirect screening of paternal perinatal depression based on maternal reporting: Protocol for a prospective longitudinal observational study.
Keita Tokumitsu, Norio Yasui-Furukori, Sheehan David Fisher, Takako Keta, Chihiro Yamada, Junko Takeuchi

Neuropsychopharmacol Rep· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody titers and neutralizing activity in cases of COVID-19 after a single dose of vaccination.
Nobumasa Okumura, Sho Saito, Yuki Takamatsu, Junko S Takeuchi, Yusuke Asai

J Infect Chemother· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralising activity and antibody titre in 10 patients with breakthrough infections of the SARS-CoV-2 Omicron variant in Japan.
Nobumasa Okumura, Shinya Tsuzuki, Sho Saito, Shin-Ichiro Hattori, Junko S Takeuchi

J Infect Chemother· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 specific T cell and humoral immune responses upon vaccination with BNT162b2: a 9 months longitudinal study.
Junko S Takeuchi, Ami Fukunaga, Shohei Yamamoto, Akihito Tanaka, Kouki Matsuda

Sci Rep· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coronavirus Disease 2019 (COVID-19) Breakthrough Infection and Post-Vaccination Neutralizing Antibodies Among Healthcare Workers in a Referral Hospital in Tokyo: A Case-Control Matching Study.
Shohei Yamamoto, Kenji Maeda, Kouki Matsuda, Akihito Tanaka, Kumi Horii, Junko S Takeuchi

Clin Infect Dis· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful use of casirivimab/imdevimab anti-spike monoclonal antibodies to enhance neutralizing antibodies in a woman on anti-CD20 treatment with refractory COVID-19.
Yusuke Miyazato, Kei Yamamoto, Yuichiro Nakaya, Shinichiro Morioka, Junko S Takeuchi

J Infect Chemother· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protocol of an Exploratory Single-Arm Study to Evaluate the Safety and Immunogenicity of KD-414 as a Booster Vaccine for SARS-CoV-2 in Healthy Adults (KAPIVARA).
Yuriko Terayama, Noriko Tomita, Junko Terada-Hirashima, Yukari Uemura, Yosuke Shimizu, Junko S Takeuchi

Life (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Association Study of HLA with the Kinetics of SARS-CoV-2 Spike Specific IgG Antibody Responses to BNT162b2 mRNA Vaccine.
Seik-Soon Khor, Yosuke Omae, Junko S Takeuchi, Ami Fukunaga, Shohei Yamamoto

Vaccines (Basel)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between reactogenicity and SARS-CoV-2 antibodies after the second dose of the BNT162b2 COVID-19 vaccine.
Shohei Yamamoto, Ami Fukunaga, Akihito Tanaka, Junko S Takeuchi, Yosuke Inoue

Vaccine· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The combination of MMSE with VSRAD and eZIS has greater accuracy for discriminating mild cognitive impairment from early Alzheimer's disease than MMSE alone.
Keita Tokumitsu, Norio Yasui-Furukori, Junko Takeuchi, Koji Yachimori, Norio Sugawara

PLoS One· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MafF Is an Antiviral Host Factor That Suppresses Transcription from Hepatitis B Virus Core Promoter.
Marwa K Ibrahim, Tawfeek H Abdelhafez, Junko S Takeuchi, Kosho Wakae, Masaya Sugiyama

J Virol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis